Last Friday, the Food and Drug Administration issued a warning letter to the direct-to-consumer genetic testing company 23andMe ordering it to stop marketing its Personal Genome Service. According to the FDA, the 23andMe genetic test is a medical device, and subject to intense regulation before it can be marketed, because “it is intended for use … Continue reading “23andMe: Victim of an Overboard FDA Crackdown, or Provocateur?”
Author: Todd Smith
Todd Smith is Director of Customer Development at Digital World Biology where he leads business development and consulting engagements. He is a founder and the former Chief Technology Officer of Geospiza. Prior to forming Geospiza in 1997, Dr. Smith was a postdoctoral scientist in Dr. Leroy Hood's laboratory at the University of Washington. Dr. Smith degrees include a Ph.D. in Medicinal Chemistry from the University of Washington, and B.S. in Genetics and Biochemistry from the University of Minnesota.
Scientists Must Change Their Culture to Bring About Better Healthcare
What do science, culture, and policy have in common? In order to improve the quality and affordability of health care, all three have to change. This message is central to Sage Bionetworks‘ mission and the theme from this year’s Sage Commons Congress held April 15th and 16th in San Francisco. What’s the problem? Biology is … Continue reading “Scientists Must Change Their Culture to Bring About Better Healthcare”